Bionano Genomics, Inc. ( BNGO) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Good day, and welcome to the Bionano Third Quarter 2025 Earnings Conference Call. Today's conference is being ...
Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...
A new technology may allow patients to recover vision for conditions that were previously thought irreversible ...
A multi-disciplinary approach was employed, using a combination of multiomic techniques, including single-cell RNA-sequencing ...
Genetic Testing Market - Test Types, Technologies and Distribution Channels" has been added to ResearchAndMarkets.com's offering. The global DTC genetic testing market is heading for significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results